Certara Inc's Corporate Customers have recorded an increase in their cost of revenue by 10.53 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 4.35 %. During the corresponding time, Certara Inc saw a revenue deteriorated by -10.81 % year on year, sequentially revenue fell by -12.76 %. While revenue at the Certara Inc 's corporate clients recorded rose by 5.07 % year on year, sequentially revenue grew by 3.93 %.
Certara Inc's Customers have recorded an increase in their cost of revenue by 10.53 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 4.35 %, for the same period Certara Inc revnue deteriorated by -10.81 % year on year, sequentially revenue fell by -12.76 %.
Certara Inc's Comment on Sales, Marketing and Customers
Our sales and marketing functions pursue a coordinated approach with a global commercial team of business development, product management, and marketing experts. Our global commercial team collaborates with our scientists, subject matter experts, and technologists to engage with customers and prospects to understand their needs and offer tailored solutions with our biosimulation software and technology-driven services. Our scientists and experts have authored thousands of scientific publications, posters, and articles to share biosimulation knowledge and methods to advance adoption. We also partner with software distributors in global regions to expand our reach.
Increasing Efficiency and Performance in Drug Formulation and Development: Certara s Simcyp Biopharmaceutics Software Certara Inc, a leading drug research and development company, has introduced the Simcyp Biopharmaceutics software, aimed at revolutionizing drug formulation and development processes. By utilizing this innovative software, biopharmaceutic, formulation, and CMC scientists will be able to formulate complex new and generic drugs faster and at a lower cost. In the third quarter of the year 2023, Certara Inc s corporate customers experienced a significant increase of 13.54% in their cost of revenue compared to the same period the previous year. Sequentially, the costs of revenue grew by 22...
Certara Inc’s Comment on Sales, Marketing and Customers
Our sales and marketing functions pursue a coordinated approach with a global commercial team of business development, product management, and marketing experts. Our global commercial team collaborates with our scientists, subject matter experts, and technologists to engage with customers and prospects to understand their needs and offer tailored solutions with our biosimulation software and technology-driven services. Our scientists and experts have authored thousands of scientific publications, posters, and articles to share biosimulation knowledge and methods to advance adoption. We also partner with software distributors in global regions to expand our reach.
Sources:
Certara Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Certara Inc’s corporate clients.
For your research, we’ve provided 9 tables on Certara Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
131.08 %
5.07 %